HOME › DRUGS › GALCANEZUMAB-GNLM
ACTIVE SUBSTANCE / INN

GALCANEZUMAB-GNLM

Brand name(s): EMGALITY
FDA LISTED
PRESCRIPTION
BLA761063
ACTIVE SUBSTANCE
Galcanezumab-Gnlm
REGULATORS
FDA
SPONSORS / MAH
ELI LILLY AND CO
TOTAL APPLICATIONS
1
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
EMGALITYBLA761063ELI LILLY AND COPrescription

FULL INTELLIGENCE ON GALCANEZUMAB-GNLM

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →